Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Gains from Investment Securities (2016 - 2025)

Abeona Therapeutics has reported Gains from Investment Securities over the past 14 years, most recently at $240000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $240000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$27.4 million (down 16.78% YoY), and the annual figure for FY2025 was $176019.0, changed 0.47%.
  • Gains from Investment Securities for Q4 2025 was $240000.0 at Abeona Therapeutics, up from -$2.8 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ABEO hit a ceiling of $8.6 million in Q2 2023 and a floor of -$24.9 million in Q2 2024.
  • Median Gains from Investment Securities over the past 5 years was $2000.0 (2021), compared with a mean of -$976977.9.
  • Peak annual rise in Gains from Investment Securities hit 36706.25% in 2022, while the deepest fall reached 305100.0% in 2022.
  • Abeona Therapeutics' Gains from Investment Securities stood at -$16000.0 in 2021, then surged by 36706.25% to $5.9 million in 2022, then tumbled by 94.49% to $323000.0 in 2023, then crashed by 99.42% to $1863.0 in 2024, then skyrocketed by 12782.45% to $240000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were $240000.0 (Q4 2025), -$2.8 million (Q3 2025), and $176148.0 (Q2 2025) per Business Quant data.